Clinical Trial Update: Injecting Botulinum Toxin A Underneath the Skin to Treat Spinal Cord Pain in Patients With Spinal Cord Injury [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating subcutaneous botulinum toxin A for neuropathic back pain in spinal cord injury patients; study terminated with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuropathic Back Pain
• Spinal Cord Injury

Drugs mentioned

• Botulinum toxin A (botulinum toxin type A)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Neuropathic Back Pain, Spinal Cord Injury | Phase 2 | Status: TERMINATED | Results posted: 2019-04-09